The invention provides aporphine and oxoaporphine compounds that have endothelial nitric oxide synthase (eNOS) maintaining or enhancing activities and may be used to manufacture a medicaments for preventing or treating ischemic diseases in human and mammal, and the ischemic diseases may include ischemic cerebral apoplexy, ischemic cerebral thrombosis, ischemic cerebral embolism, hypoxic ischemic encephlopathy, ischemic cardiac disease or ischemic enteropathy etc.
该发明提供了具有内皮
一氧化氮合酶(eNOS)维持或增强活性的阿泼啡和氧化阿泼啡化合物,可用于制造预防或治疗人类和哺乳动物缺血性疾病的药物,这些缺血性疾病包括缺血性脑卒中、缺血性脑血栓、缺血性脑栓塞、缺氧性缺血性脑病、缺血性心脏病或缺血性肠病等。